Vivani Medical, Inc. (NASDAQ:VANI) Director Gregg Williams Purchases 3,968,253 Shares

Vivani Medical, Inc. (NASDAQ:VANI - Get Free Report) Director Gregg Williams purchased 3,968,253 shares of Vivani Medical stock in a transaction dated Friday, November 8th. The shares were bought at an average cost of $1.26 per share, for a total transaction of $4,999,998.78. Following the transaction, the director now directly owns 4,695,861 shares of the company's stock, valued at approximately $5,916,784.86. The trade was a 500.00 % increase in their position. The purchase was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.

Vivani Medical Stock Performance

Shares of NASDAQ VANI traded up $0.14 during midday trading on Wednesday, hitting $1.39. The company's stock had a trading volume of 857,840 shares, compared to its average volume of 1,026,799. Vivani Medical, Inc. has a 1-year low of $0.84 and a 1-year high of $7.80. The firm's fifty day moving average price is $1.22 and its 200-day moving average price is $1.36. The firm has a market cap of $76.81 million, a P/E ratio of -2.96 and a beta of 3.20.

Vivani Medical (NASDAQ:VANI - Get Free Report) last posted its earnings results on Tuesday, August 13th. The company reported ($0.10) EPS for the quarter, beating the consensus estimate of ($0.12) by $0.02.

Analysts Set New Price Targets

Separately, HC Wainwright started coverage on Vivani Medical in a research note on Thursday, November 7th. They set a "buy" rating and a $3.00 price objective on the stock.

Vivani Medical Company Profile

Vivani Medical, Inc, a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals.